10 Best Performing NASDAQ Stocks According to Wall Street Analysts
On April 28, Tom Lee of Fundstrat joined CNBC's 'Power Lunch' to discuss the outlook for equity markets.
Opus Genetics Inc. (IRD)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Caligan Partners David Johnson | 6,075,028 | $27,641,377 | 1.84% | |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 6,029,775 | $27,435,476 | +446% | 0.04% |
| 3. | Balyasny Asset Management Dmitry Balyasny | 2,718,029 | $12,367,032 | 0.02% | |
| 4. | Millennium Management Israel Englander | 2,630,432 | $11,968,466 | +32% | 0% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 2,313,380 | $10,525,879 | +1368% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.97 | 83,000 | $163,418.70 | 83,000 | 2025-12-29 | Filing | |
| $1.98 | 81,000 | $160,274.70 | 1,891,430 | 2025-12-29 | Filing | |
| $0.98 | 100,000 | $97,600.00 | 599,150 | 2024-12-26 | Filing | |
| $0.98 | 10,000 | $9,834.00 | 342,800 | 2024-11-21 | Filing | |
| $1.02 | 9,706 | $9,942.83 | 492,950 | 2024-11-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.24 | 7,470 | $39,121.14 | 711,535 | 2026-04-23 | Filing | |
| $5.22 | 4,697 | $24,519.28 | 296,084 | 2026-04-23 | Filing | |
| $5.20 | 1,641 | $8,539.76 | 188,671 | 2026-04-23 | Filing | |
| $5.22 | 9,511 | $49,647.42 | 1,741,344 | 2026-04-23 | Filing | |
| $5.19 | 7,542 | $39,155.80 | 509,233 | 2026-04-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,683,429 | $16,759,602 | 31.7% | |
| 2. | 2,449,987 | $11,147,441 | 0% | |
| 3. | 1,189,113 | $5,410,464 | 0.07% | |
| 4. | 823,383 | $3,746,393 | 0% | |
| 5. | 736,842 | $3,352,631 | 0.58% |
News See All
Citizens Initiates Coverage of Opus Genetics (IRD)
Opus Genetics, Inc. (NASDAQ:IRD) is one of the best performing small cap stocks so far in 2026. On April 28, Citizens initiated coverage of Opus Genetics, Inc.
10 Best Performing Small Cap Stocks So Far in 2026
Talking about the hiccup in tech, she was of the view that we are going to go through this over and over again, which includes worries about whether or not spending can keep up.
BTIG Raises its Price Target on Opus Genetics, Inc. (IRD) to $12 from $7 and Maintains a Buy Rating
On March 2, 2026, BTIG raised the price target on Opus Genetics, Inc. (NASDAQ:IRD) to $12 from $7 and maintained a Buy rating.
Piper Sandler Initiates Coverage on Opus Genetics, Inc. (IRD) With “Overweight” Rating and $7 PT
On November 25, 2025, The Fly reported that Piper Sandler initiated coverage of Opus Genetics, Inc. (NASDAQ:IRD) with an “Overweight” rating and a $7 price target.
12 Hot Penny Stocks to Invest in Right Now
Goldman Sachs Asset Management portfolio manager Greg Tuorto appeared on CNBC on November 17, 2025.
Hedge Fund Resource Center